The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial (334814)
ARTG Name
ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial
Product name
ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
Bevacizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information